Exendin (5-39) - ≥99% , CAS No.196109-27-0

CAS: 196109-27-0 Cat. No.: E647553 分子式: C169H262N44O54S 分子量: 3806.30
注文可能
グレード&純度 ≥99%
Storage
Protected from light,Argon charged,Desiccated,Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
サイズ
USA
ドイツ (EU)*
価格
個数
1mg
E647553-1mg
受注生産 · 8~12週間
$520.90
5mg
E647553-5mg
受注生産 · 8~12週間
$1,160.90
10mg
E647553-10mg
受注生産 · 8~12週間
$1,900.90
Enter a quantity for the sizes you want to add.

概要

Exendin (5-39) is a potent Glukagon-like peptide 1 ( GLP-1 ) receptor antagonist. Exendin (5-39) improves memory impairment in β-amyloid protein-treated rats

In Vivo

Exendin (5-39) (intracerebroventricular injection; 0.3 μg; once daily; 1-week) increases GLT-1 protein levels in the hippocampus of male Wistar rats. Additionally, hippocampal slices are prepared from Ex-treated or vehicle rats,Exendin (5-39) decreases fEPSP decay time and increases the input-output relation and decreased the paired-pulse ratio in the dentate gyrus (DG). Furthermore, Ex inhibits long-term depression but not long-term potentiation in the DG . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Wistar rats (3 weeks old and 18 days pregnant) Dosage: 0.3 μg Administration: Intracerebroventricular injection; 0.3 μg; once daily; 1-week Result: Inhibited GLT-1 protein levels and inhibited long-term depression in rats.

Form:Solid

IC50& Target:IC50: GLP-1 receptor

仕様

仕様と純度
≥99%
生化学的・生理学的メカニズム
Exendin (5-39) is a potent Glukagon-like peptide 1 ( GLP-1 ) receptor antagonist. Exendin (5-39) improves memory impairment in β-amyloid protein-treated rats.
保管条件
Protected from light,Argon charged,Desiccated,Store at -80°C
入荷
Dry ice packs + Cold packs
この製品は冷冷この冷このこの製品の運送が必要です。地上およびその他の経済サービスは利用できません。
アクションタイプ
ANTAGONIST
純度
≥99%
名前と識別子
分子量
3806.30

詳細データ

証明書(CoA、COO、BSE/TSEと分析図)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
ソリューション計算機
レビュー

顧客レビュー

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.